Report Categories
View AllRecent Articles
View All
XRX Xerox posts negative 199 percent Q4 2025 EPS surprise dragging shares down 126 percent today
Why Tecogen TGEN could be the turning point youve been waiting for Market Focus 20260506
NSAB National sees resilient selfstorage demand supporting steady operating performance through coming quarters
Is Magnera Corporation MAGN stock failing at resistance Q1 2026 EPS Misses Estimates
Nvidia Earnings Call in Focus China Chip Restrictions and Political Commentary Could Sway Markets
Trump Seeks Supreme Court Intervention to Halt TikTok Ban
West Asia Tensions and Austerity Measures May Slow Indias Fuel Demand Growth in 2026
GoldBacked Lenders in India Poised for Growth as Higher Import Tariffs Shift Borrower Behavior
Reddit Shares Slide as Meta Launches Competing Forum App
SEBI Chief Tuhin Kanta Pandey Indias Market Diversification Outshines Taiwans AIDriven Rally
LOOP Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Development
PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances
CVEO Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Market Reaction
MU Q1 2026 Earnings Stellar EPS Beat Drives Stock Surge
AMWD Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
EMBJ Q1 2026 Earnings EPS Falls Short of Estimates as Shares Edge Higher
abrdn Global Premier Properties Fund AWP Edges Higher Amid Modest Gains and RangeBound Trading
Illumination Acquisition Corp I Units ILLUU Holds Steady Near 10 as SPAC Units Trade in Tight Range
QuantumSi QSI Surges 7 as Shares Test Key Resistance Level
Hess Midstream HESM Lifted by Sector Momentum Key Levels After the 212 Move
Community Bancorp CMTV Edges Lower Amid Light Trading Key Levels Under Watch
External Links
Bond Bull Market Shows Signs of Pause but Remains Resilient Expert Suggests
Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4
MKS Inc MKSI Edges Lower as Stock Navigates Between Key Support and Resistance Levels
Akebia Therapeutics Inc AKBA Q1 2026 Earnings EPS Misses Estimates Slightly Stock Unchanged
BBY Q1 2026 Earnings EPS Beats Estimates by 481 Stock Inches Higher
NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase
AMCX Q1 2026 Earnings EPS Misses Estimates by Over 62 Stock Still Rises 267
Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip
OCUL Q1 2026 Earnings WiderthanExpected Loss Highlights DevelopmentStage Costs
AMWD Q1 2026 Earnings EPS Surges Past Estimates with 60 Beat